Marie-Jose B Quentin-Millet

This inventor holds 7 USPTO granted patents. Top assignees: Institut Merieux, Pasteur Merieux Serums & Vaccins, Pasteau Merieux Serums Et Vaccins. Active years: 1988-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marie-Jose B Quentin-Millet. Retrieved from https://idiyas.com/inventor/marie-jose-b-quentin-millet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 61(Granted Patents)

Company Filing History:

Pasteur Merieux Serums & Vaccins

patents

1 out of 1

Pasteau Merieux Serums Et Vaccins

patent

Years Active: 1988-2000

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6126938 - Methods for inducing a mucosal immune response (2000-10-03),

2. 6086893 - Helicobacter lactoferrin receptor (2000-07-11),

3. 5618541 - Vaccine against Neisseria meningitidis infections (1997-04-08),

4. 5045203 - Separation of protein antigens of Bordetella bacteria by affinity (1991-09-03),

5. 4985144 - Affinity chromatography material for antigens of the bacteria of the (1991-01-15),

6. 4965205 - Culture medium for bacteria of the bordetella genus containing (1990-10-23),

7. 4774086 - Process for the purification, solubilization and/or detoxification of (1988-09-27),

Title: The Innovative Contributions of Marie-Jose B Quentin-Millet

Introduction

Marie-Jose B Quentin-Millet, a notable inventor based in Villeurbanne, France, has made significant contributions to the field of immunology. With a remarkable portfolio of 7 patents, her work has advanced the understanding and application of mucosal immune responses in pharmaceutical compositions.

Latest Patents

Among her latest innovative patents is a groundbreaking method for inducing a mucosal immune response. This invention revolves around a pharmaceutical composition intended to elicit a protective immune response against antigens in mammalian hosts. The formulation comprises at least two products that contain an inducing agent for the immune response, specifically targeting the naso-oropharynx or salivary glands through the nasobuccal route. Additionally, the method allows for a third product formulated for systemic administration, showcasing Marie-Jose's commitment to enhancing vaccine efficacy and immune system activation.

Career Highlights

Marie-Jose has had an illustrious career, having worked with esteemed organizations such as Pasteur Merieux Serums & Vaccins and Institut Merieux. These institutions have provided her with a platform to develop her innovative ideas and contribute to significant advancements in immunological research.

Collaborations

Throughout her career, Marie-Jose has collaborated with distinguished colleagues, including Francois Arminjon and Bruno Guy. These partnerships have fostered the exchange of ideas and contributed to the successful development of her patents, highlighting the importance of teamwork in scientific innovation.

Conclusion

In conclusion, Marie-Jose B Quentin-Millet's ingenuity and dedication to her field are evident through her innovative patents and fruitful collaborations. Her work continues to pave the way for advancements in immunology, making her a prominent figure in the realm of scientific innovation.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]